Skip to main content
. 2020 Feb 27;15(2):e0229517. doi: 10.1371/journal.pone.0229517

Table 5. Adverse events of therapy.

SOF+Peg-IFN+RBV (n = 70) SOF+LDV (n = 52) SOF+LDV+RBV (n = 63) Total (N = 185)
Fatigue 17 (24.3) 4 (7.7) 6 (9.5) 27 (14.6)
Anemia 9 (12.9) 0 (0.0) 5 (7.9) 14 (7.6)
Headache 6 (8.6) 3 (5.8) 4 (6.3) 13 (7.0)
Flu-like symptoms 12 (17.1) 0 (0.0) 0 (0.0) 12 (6.5)
Nausea 7 (10.0) 1 (1.9) 2 (3.2) 10 (5.4)
Neutropenia 6 (8.6) 0 (0.0) 0 (0.0) 6 (3.2)

SOF: Sofosbuvir; Peg-IFN: Pegylated interferon; RBV: Ribavirin; LDV: ledipasvir.